RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma. [PDF]
Utrilla-Maestre A +6 more
europepmc +1 more source
Correction: Dhillon et al. Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review. <i>Cancers</i> 2025, <i>17</i>, 3610. [PDF]
Dhillon V +2 more
europepmc +1 more source
Survival of myelodysplastic syndrome patients after azacitidine therapy. [PDF]
Thammagul K +5 more
europepmc +1 more source
Emerging applications of long-read sequencing in hematological malignancies: highlights from the 2025 ASH annual meeting. [PDF]
Liu B, Jiang Y, Zhao B, Zhu HH.
europepmc +1 more source
Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma. [PDF]
Yang K, Wu D.
europepmc +1 more source
A novel spliceosomopathy caused by de novo SF3B3 variants. [PDF]
Musante L +48 more
europepmc +1 more source
Distinct and convergent effects of <i>SF3B1</i> mutations in human breast cancer. [PDF]
Bergman RE +21 more
europepmc +1 more source
Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. [PDF]
Zhang L +9 more
europepmc +1 more source
IGF2BP3 inhibition: another home run for RNA-binding protein targeting in hematological malignancies. [PDF]
Penalva LOF.
europepmc +1 more source
Fbrsl1 is required for cranial neural crest development and reflects a conserved function of the human disease-associated protein. [PDF]
Gerstner S +6 more
europepmc +1 more source

